Literature DB >> 20947410

Interleukin-26: an IL-10-related cytokine produced by Th17 cells.

Raymond P Donnelly1, Faruk Sheikh, Harold Dickensheets, Ram Savan, Howard A Young, Mark R Walter.   

Abstract

IL-26 is classified as a member of the IL-10 cytokine family because it has limited sequence homology to IL-10 and the IL-10-related cytokines. The human IL-26 gene, IL26, is located on chromosome 12q15 between the genes for two other important class-2 cytokines, IFNG (IFN-γ) and IL22 (IL-22). IL-26 is often co-expressed with IL-22 by activated T cells, especially Th17 cells. It signals through a heterodimeric receptor complex composed of the IL-20R1 and IL-10R2 chains. IL-26 receptors are primarily expressed on non-hematopoietic cell types, particularly epithelial cells. Signaling through IL-26 receptor complexes results in the activation of STAT1 and STAT3 with subsequent induction of IL-26-responsive genes. The biological functions of IL-26 have only begun to be defined. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947410      PMCID: PMC2997847          DOI: 10.1016/j.cytogfr.2010.09.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  53 in total

1.  Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; E Esterova; H Dickensheets; R P Donnelly; S Pestka
Journal:  J Biol Chem       Date:  2000-10-16       Impact factor: 5.157

2.  Novel polymorphisms in the IL-10 related AK155 gene (chromosome 12q15).

Authors:  A Goris; M G Marrosu; K Vandenbroeck
Journal:  Genes Immun       Date:  2001-08       Impact factor: 2.676

3.  Interleukin 20: discovery, receptor identification, and role in epidermal function.

Authors:  H Blumberg; D Conklin; W F Xu; A Grossmann; T Brender; S Carollo; M Eagan; D Foster; B A Haldeman; A Hammond; H Haugen; L Jelinek; J D Kelly; K Madden; M F Maurer; J Parrish-Novak; D Prunkard; S Sexson; C Sprecher; K Waggie; J West; T E Whitmore; L Yao; M K Kuechle; B A Dale; Y A Chandrasekher
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

4.  Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; E Esterova; H Dickensheets; R P Donnelly; S Pestka
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

5.  Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types.

Authors:  L Dumoutier; C Leemans; D Lejeune; S V Kotenko; J C Renauld
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

6.  Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site.

Authors:  K Josephson; N J Logsdon; M R Walter
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

7.  Structure and mechanism of receptor sharing by the IL-10R2 common chain.

Authors:  Sung-Il Yoon; Brandi C Jones; Naomi J Logsdon; Bethany D Harris; Ashlesha Deshpande; Svetlana Radaeva; Brian A Halloran; Bin Gao; Mark R Walter
Journal:  Structure       Date:  2010-05-12       Impact factor: 5.006

8.  Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri.

Authors:  A Knappe; S Hör; S Wittmann; H Fickenscher
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Cutting edge: immune cells as sources and targets of the IL-10 family members?

Authors:  Kerstin Wolk; Stefanie Kunz; Khusru Asadullah; Robert Sabat
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

10.  A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta.

Authors:  B H Gruenberg; A Schoenemeyer; B Weiss; L Toschi; S Kunz; K Wolk; K Asadullah; R Sabat
Journal:  Genes Immun       Date:  2001-10       Impact factor: 2.676

View more
  47 in total

1.  Microarray analysis of Mycobacterium tuberculosis-infected monocytes reveals IL26 as a new candidate gene for tuberculosis susceptibility.

Authors:  José M Guerra-Laso; Sara Raposo-García; Silvia García-García; Cristina Diez-Tascón; Octavio M Rivero-Lezcano
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

2.  IL-26 contributes to host defense against intracellular bacteria.

Authors:  Angeline Tilly Dang; Rosane Mb Teles; David I Weiss; Kislay Parvatiyar; Euzenir N Sarno; Maria T Ochoa; Genhong Cheng; Michel Gilliet; Barry R Bloom; Robert L Modlin
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

3.  IL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells.

Authors:  David I Weiss; Feiyang Ma; Alexander A Merleev; Emanual Maverakis; Michel Gilliet; Samuel J Balin; Bryan D Bryson; Maria Teresa Ochoa; Matteo Pellegrini; Barry R Bloom; Robert L Modlin
Journal:  J Immunol       Date:  2019-06-24       Impact factor: 5.422

4.  IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with Neutrophils.

Authors:  Timothy N Trotter; Casey W Shuptrine; Li-Chung Tsao; Robert D Marek; Chaitanya Acharya; Jun-Ping Wei; Xiao-Yi Yang; Gangjun Lei; Tao Wang; Herbert Kim Lyerly; Zachary C Hartman
Journal:  Cancer Res       Date:  2020-05-04       Impact factor: 12.701

5.  Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.

Authors:  Kei Ohnuma; Ryo Hatano; Thomas M Aune; Haruna Otsuka; Satoshi Iwata; Nam H Dang; Taketo Yamada; Chikao Morimoto
Journal:  J Immunol       Date:  2015-03-18       Impact factor: 5.422

6.  IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis.

Authors:  Ellen Witte; Georgios Kokolakis; Katrin Witte; Sandra Philipp; Wolf-Dietrich Doecke; Nina Babel; Bianca M Wittig; Katarzyna Warszawska; Agata Kurek; Magdalena Erdmann-Keding; Stefanie Kunz; Khusru Asadullah; Marshall E Kadin; Hans-Dieter Volk; Wolfram Sterry; Kerstin Wolk; Robert Sabat
Journal:  J Invest Dermatol       Date:  2014-07-21       Impact factor: 8.551

7.  Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis.

Authors:  Ryo Hatano; Takumi Itoh; Haruna Otsuka; Sayo Okamoto; Eriko Komiya; Satoshi Iwata; Thomas M Aune; Nam H Dang; Kyoko Kuwahara-Arai; Kei Ohnuma; Chikao Morimoto
Journal:  MAbs       Date:  2019-08-18       Impact factor: 5.857

8.  T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26.

Authors:  Stephan Meller; Jeremy Di Domizio; Kui S Voo; Heike C Friedrich; Georgios Chamilos; Dipyaman Ganguly; Curdin Conrad; Josh Gregorio; Didier Le Roy; Thierry Roger; John E Ladbury; Bernhard Homey; Stanley Watowich; Robert L Modlin; Dimitrios P Kontoyiannis; Yong-Jun Liu; Stefan T Arold; Michel Gilliet
Journal:  Nat Immunol       Date:  2015-07-13       Impact factor: 25.606

9.  Interleukin-26 Production in Human Primary Bronchial Epithelial Cells in Response to Viral Stimulation: Modulation by Th17 cytokines.

Authors:  Karlhans Fru Che; Riitta Kaarteenaho; Elisa Lappi-Blanco; Bettina Levänen; Jitong Sun; Åsa Wheelock; Lena Palmberg; C Magnus Sköld; Anders Lindén
Journal:  Mol Med       Date:  2017-08-29       Impact factor: 6.354

10.  Interleukin-26 upregulates interleukin-22 production by human CD4+ T cells in tuberculous pleurisy.

Authors:  Min Zhang; Yi-Ran Niu; Jing-Yuan Liu; Xiao-Shan Wei; Xiao-Rong Wang; Lin-Lin Ye; Wen-Bei Peng; Jian-Chu Zhang; Xiao-Nan Tao; Qiong Zhou
Journal:  J Mol Med (Berl)       Date:  2019-03-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.